These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11256730)

  • 1. Effective detection of HIV.
    Rotheram-Borus MJ; Newman PA; Etzel MA
    J Acquir Immune Defic Syndr; 2000 Dec; 25 Suppl 2():S105-14. PubMed ID: 11256730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection: the next steps.
    Merson MH
    J Acquir Immune Defic Syndr; 2000 Dec; 25 Suppl 2():S157-9. PubMed ID: 11256737
    [No Abstract]   [Full Text] [Related]  

  • 3. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.
    Forsyth AD; Valdiserri RO
    Curr Opin HIV AIDS; 2012 Mar; 7(2):111-6. PubMed ID: 22227586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV epidemiology, testing strategies, and prevention interventions.
    Buchbinder S
    Top HIV Med; 2010; 18(2):38-44. PubMed ID: 20516523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessing HIV testing and care.
    Galvan FH; Bing EG; Bluthenthal RN
    J Acquir Immune Defic Syndr; 2000 Dec; 25 Suppl 2():S151-6. PubMed ID: 11256736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in HIV seropositivity in publicly funded HIV counseling and testing programs: implications for prevention policy.
    Valdiserri RO; Weber JT; Frey R
    Am J Prev Med; 1998 Jan; 14(1):31-42. PubMed ID: 9476834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV treatment as prevention: [corrected] next steps.
    Duerr A
    Curr Opin HIV AIDS; 2012 Mar; 7(2):97-8. PubMed ID: 22241162
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
    Lohse N
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV risk, prevention, and testing behaviors among men who have sex with men--National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008.
    Finlayson TJ; Le B; Smith A; Bowles K; Cribbin M; Miles I; Oster AM; Martin T; Edwards A; Dinenno E;
    MMWR Surveill Summ; 2011 Oct; 60(14):1-34. PubMed ID: 22031280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
    Holtgrave DR
    PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous HIV testing among adults and adolescents newly diagnosed with HIV infection - National HIV Surveillance System, 18 jurisdictions, United States, 2006-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):441-5. PubMed ID: 22717512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV seropositivity rates in outreach-based counseling and testing services: program evaluation.
    DiFranceisco W; Holtgrave DR; Hoxie N; Reiser WJ; Resenhoeft R; Pinkerton SD; Vergeront J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):282-8. PubMed ID: 9803971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying barriers to HIV testing: personal and contextual factors associated with late HIV testing.
    Schwarcz S; Richards TA; Frank H; Wenzel C; Hsu LC; Chin CS; Murphy J; Dilley J
    AIDS Care; 2011 Jul; 23(7):892-900. PubMed ID: 21424942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--National HIV Behavioral Surveillance System, 21 U.S. cities, 2010.
    Sionean C; Le BC; Hageman K; Oster AM; Wejnert C; Hess KL; Paz-Bailey G; ;
    MMWR Surveill Summ; 2014 Dec; 63(14):1-39. PubMed ID: 25522191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised guidelines for HIV counseling, testing, and referral.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2001 Nov; 50(RR-19):1-57; quiz CE1-19a1-CE6-19a1. PubMed ID: 11718472
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.